ELN Software Industry: 100 Statistics & Trends 2026

📈

Market Size & Growth Projections

Stats #1–18

$700M → $720M

The global ELN market grew from $700M in 2024 to ~$720M in 2025, reflecting robust double-digit momentum as laboratory digitisation accelerates across life sciences globally. (MarketsandMarkets, PRNewswire, 2025)

$1.03 Billion

The ELN market is projected to reach $1.03B by 2030 at a CAGR of 7.3% — a milestone that signals the software's transition from niche research tool to enterprise-grade R&D infrastructure. (MarketsandMarkets, 2025)

$512.45M

Mordor Intelligence estimates the 2026 ELN market at $512.45M (using its segmented framework), growing from $480.44M in 2025 — indicating consistent annual growth of over $30M year-on-year. (Mordor Intelligence, 2026)

$1.4 Billion

Some projections place the ELN market at $1.4B by 2034 at a CAGR of 7.26%, indicating that the sector's long-term growth story is firmly underpinned by lab automation and data integrity demands. (Toward Healthcare, 2026)

$595.58M (2024)

Verified Market Research values the 2024 ELN software market at $595.58M, with projections reaching $860M by 2032 at a CAGR of 4.7% — demonstrating sustained, resilient market expansion. (Verified Market Research, 2025)

$1.2B → $2.8B

ELN software specifically (broader definition) was estimated at $1.2B in 2024 and is expected to reach $2.8B by 2033 at a 10.5% CAGR, driven by cloud expansion and AI feature integration. (Verified Market Reports, 2025)

6.66% CAGR

Mordor Intelligence forecasts a 6.66% CAGR from 2026 to 2031, with the ELN market reaching $707M by 2031 — reinforcing that regulatory compliance and digital transformation are enduring growth catalysts. (Mordor Intelligence, 2026)

$613.5M (2023)

The global ELN market stood at $613.5M in 2023 and is forecast to reach $1.276B by 2033 at a 7.6% CAGR — a near-doubling that underscores the sector's shift from paper to digital at scale. (Market.US, 2024)

$709.95M (2024)

Reanin pegs the ELN software market at $709.95M in 2024, with projections reaching $972.63M by 2031 at a 4.6% CAGR, highlighting diverse analyst estimates across different market definitions. (Reanin, 2025)

#10

8.5% CAGR

Coherent Market Insights projects an 8.5% CAGR, with the ELN market crossing $922M by 2032 from $521M in 2025 — making ELN one of the faster-growing subsegments within lab informatics software. (Coherent Market Insights, 2025)

#11

$392M (2023)

Allied Market Research valued the ELN market at $392M in 2023, forecasting growth to $841.7M by 2033 at 7.9% CAGR — consistent with the broader trend of science-driven digital adoption. (Allied Market Research)

#12

$566M (2023)

SkyQuestTT valued the ELN market at $566M in 2023, growing to $871M by 2032 at 4.9% CAGR, with Thermo Fisher, Benchling, and LabVantage leading competitive dynamics. (SkyQuestTT, 2025)

#13

$255M (US, 2024)

The US ELN market alone was valued at $255.19M in 2024, projected to nearly double to $447.82M by 2034 — reflecting America's leadership as the world's most mature ELN adoption market. (Precedence Research, 2025)

#14

$133.3M (Cloud US)

The US cloud ELN service market specifically was valued at $133.3M in 2025, expected to surge to $412.9M by 2035 at a 12% CAGR — cloud is becoming the primary ELN delivery mechanism in North America. (Future Market Insights, 2025)

#15

$650M → $1.4B

DataIntelo projects the ELN market growing from $650M in 2023 to $1.4B by 2032 at 8.9% CAGR, driven by collaborative platform demand and R&D complexity in pharmaceutical and biotech sectors. (DataIntelo, 2024)

#16

$0.6B → $1.1B

Future Market Insights sizes the ELN market at $0.6B in 2025, forecasting $1.1B by 2035 at 6.5% CAGR, with LIMS integration driving the majority of enterprise deal expansion through 2030. (Future Market Insights, 2025)

#17

40 Exabytes

Life sciences laboratories produce roughly 40 exabytes of data annually as of 2025 — a staggering data burden that makes structured, searchable ELN repositories an operational necessity, not a luxury. (Scispot via Mordor Intelligence, 2026)

#18

120+ Vendors

Over 120 ELN vendors operate globally in 2025, yet the top 5 firms control approximately 55% of the market — a moderately concentrated landscape ripe for further consolidation through M&A. (Industry Research Biz, 2026)

☁️

Adoption Rates & Deployment Trends

Stats #19–38

Deployment & Adoption Breakdown (2025)

Cloud-Based ELN Deployment67.92%

Research Facilities with ELN Adopted64%

ELN Deployments with AI/ML Features58%

R&D Teams Using Hybrid Cloud+On-Prem42%

Labs Adopting COVID-Accelerated Digital Plans77%

#19

67.92% Cloud Share

Cloud platforms held 67.92% of the ELN market in 2024 — a striking shift for a sector once wary of off-premise computing, signalling that security concerns have been largely overcome. (Mordor Intelligence, 2026)

#20

64% Adoption Rate

About 64% of research facilities globally have adopted ELN platforms to boost productivity and improve experimental documentation — leaving a significant 36% growth opportunity. (Reanin, 2025)

#21

58% with AI/ML

58% of current ELN deployments include AI/ML features in 2025, converting notebooks from passive record systems into active, intelligent research assistants that flag anomalies and suggest actions. (Industry Research Biz, 2026)

#22

42% Hybrid Models

42% of R&D teams now adopt hybrid cloud+on-premises ELN models — a pragmatic approach balancing scalability and remote access with data sovereignty and compliance requirements. (Industry Research Biz, 2026)

#23

77% COVID Effect

77% of laboratory leaders reported that the COVID-19 pandemic accelerated their digital transformation plans — permanently reshaping lab informatics priorities toward cloud-accessible, remote-friendly ELN tools. (Technology Networks, 2024)

#24

50% AI Planning

50% of new ELN contracts signed in 2024 include an AI-driven experiment planning module — signalling a decisive industry pivot toward predictive lab workflows that reduce trial-and-error experimentation. (Industry Research Biz, 2026)

#25

68% Collab Modules

In 2025, about 68% of new ELN purchases include collaboration and workflow modules, reflecting researchers' demand for real-time shared notebooks far beyond simple digital note-taking. (Industry Research Biz, 2026)

#26

70% Software Revenue

Software components represent more than 70% of ELN market revenue, with services (implementation, training, support) accounting for the remainder — though services are growing fastest as deployments scale. (Industry Research Biz, 2026)

#27

9.1% Software CAGR

The software component of ELN is expanding at a 9.1% CAGR — outpacing the overall market — driven by feature-rich cloud SaaS offerings and AI integrations accelerating upsell cycles. (MarketsandMarkets, 2025)

#28

65% Cloud US Share

Cloud ELN software held a 65% share of total US cloud ELN demand in 2025, with the software component's dominance driven by real-time capture, efficient record-keeping, and easy cross-team data sharing. (Future Market Insights, 2025)

#29

55.45% Cross-Disc.

Cross-disciplinary ELNs hold a 55.45% market share, reflecting labs' need for unified platforms spanning chemistry, biology, and analytical functions — avoiding costly duplicate systems. (Mordor Intelligence, 2026)

#30

75.2% Cross-Disc. (2023)

Cross-disciplinary ELNs commanded an even larger 75.2% share in 2023 — though specific ELNs are now gaining ground rapidly at an 8% CAGR as specialized research needs intensify. (Grand View Research)

#31

8.0% Specific ELN CAGR

Specific ELNs are the fastest-growing product segment at an 8.0% CAGR, as pharma, biotech, and clinical research teams demand purpose-built tools over generic solutions. (MarketsandMarkets, 2025)

#32

<20% India Adoption

Despite India hosting over 3,000 biotech and pharma R&D labs, fewer than 20% use advanced ELN — representing a massive untapped opportunity for vendors offering localised, lower-cost deployment models. (Industry Research Biz, 2026)

#33

~22% China Adoption

China's ELN uptake remains at ~22% despite hosting more than 4,500 life sciences research institutions in 2024 — an indicator of significant untapped digitalisation potential in the world's second-largest R&D market. (Industry Research Biz, 2026)

#34

36.4% LIMS Segment

LIMS (Laboratory Information Management Systems) leads the ELN solution market with a 36.4% share in 2025, reflecting the convergence of ELN and LIMS functions into integrated lab informatics platforms. (Future Market Insights, 2025)

#35

34% Collaboration Tools

34% of new ELN contracts in 2024 specifically include collaboration tools — reflecting a shift from individual record-keeping toward team-based, real-time scientific knowledge management. (Industry Research Biz, 2026)

#36

200,000+ Benchling Users

Benchling's freemium model has attracted over 200,000 bench scientists — providing invaluable user-experience telemetry that guides its product roadmap and accelerates feature adoption across enterprise clients. (Mordor Intelligence, 2026)

#37

12% Academic Segment

Academic research institutions represent approximately 12% of the ELN software market, valuing open access, reproducibility, and open-source options — though adoption in universities remains relatively low overall. (Reanin, 2025)

#38

60% Proprietary Licensing

Proprietary licensing accounts for approximately 60% of ELN installations versus 40% open-source — though open-source options like eLabFTW are gaining traction in resource-constrained academic settings. (Industry Research Biz, 2026)

🌍

Regional Market Breakdown

Stats #39–52

40%

North America Share

Largest regional market in 2024–2025, led by US pharma, biotech, and regulatory compliance investments.

25–30%

Europe Share

Second-largest region; Germany, UK, France lead. Cloud ELN Europe market = $225.8M in 2024.

~25%

Asia Pacific Share

Fastest-growing region. Cloud ELN APAC market = $164.7M in 2024 at 15.1% CAGR.

#39

37.65% NA Share (2025)

North America commanded 37.65% of the global ELN market in 2025, supported by a well-established research ecosystem, early digital adoption, and stringent FDA and GxP regulatory enforcement. (Mordor Intelligence, 2026)

#40

8.71% APAC CAGR

Asia-Pacific is projected to record the highest regional ELN CAGR of 8.71% through 2031, fuelled by China and India's outsourcing-driven R&D growth and government-backed lab digitalisation programs. (Mordor Intelligence, 2026)

#41

$225.8M (Europe Cloud)

Europe's cloud ELN market stood at $225.8M in 2024, backed by strong government initiatives promoting healthcare digitalisation and stringent GDPR-aligned data management requirements. (Growth Market Reports, 2025)

#42

15.1% APAC Cloud CAGR

Asia-Pacific's cloud ELN market is growing at a 15.1% CAGR through 2033 — the fastest of any region — as China, India, and Southeast Asia collectively ramp up pharmaceutical manufacturing and R&D outsourcing. (Growth Market Reports, 2025)

#43

12.2% Europe CAGR

The European cloud ELN market is growing at 12.2% CAGR through 2033, propelled by ongoing investments in research infrastructure and intensifying industry-academia collaboration. (Growth Market Reports, 2025)

#44

$164.7M (APAC Cloud)

Asia-Pacific's cloud ELN market was valued at $164.7M in 2024, with growth driven by increasing pharmaceutical CRO activity and expanding university research budgets across the region. (Growth Market Reports, 2025)

#45

12.3% US South CAGR

Within the US, the Southern region leads cloud ELN growth at a 12.3% CAGR, as pharmaceutical and biotech industries in states like North Carolina and Texas embrace cloud-first digital lab solutions. (Future Market Insights, 2025)

#46

5.74% US CAGR

The US ELN market is growing at 5.74% CAGR from 2025–2034, a reliable baseline reflecting America's mature but steadily expanding research infrastructure and pharma R&D investments. (Precedence Research, 2025)

#47

40% North Am. Cloud Share

North America leads the global ELN software market with over 40% share, driven by robust regulatory enforcement (FDA 21 CFR Part 11) and the presence of 80%+ of global pharma R&D headquarters. (Reanin, 2025)

#48

Singapore R&D Hub

In August 2024, Skills Corporation opened a new R&D Center in Singapore to support ELN adoption across Asia-Pacific, developing multilingual compliance features tailored to diverse regional regulatory structures. (Coherent Market Insights, 2025)

#49

$447.82M (US 2034)

The US ELN market is projected to reach $447.82M by 2034 — nearly doubling its 2024 value of $255M — as pharmaceutical innovation cycles and genomics-led research continue to intensify. (Precedence Research, 2025)

#50

30% Asia-Pacific (2023)

Asia-Pacific held a 30% share of global ELN revenue in 2023 — second only to North America — driven by India and China's pharmaceutical CRO boom and government-funded digital science initiatives. (Verified Market Reports, 2025)

#51

4,500+ China Life Sci Orgs

China's life sciences research institutions exceeded 4,500 in 2024, yet ELN uptake remained at only ~22% — underscoring a massive greenfield opportunity for ELN vendors with localised, cost-effective solutions. (Industry Research Biz, 2026)

#52

$412.9M (US Cloud 2035)

The US cloud ELN market is set to grow from $133.3M (2025) to $412.9M by 2035 — a 3× expansion reflecting the shift of laboratory operations from on-premise to scalable cloud environments. (Future Market Insights, 2025)

🔬

End-User Segments & Industry Applications

Stats #53–68

#53

46.12% Pharma/Biotech

Pharmaceutical and biotechnology companies accounted for 46.12% of the ELN market in 2025 — the dominant end-user segment, driven by drug discovery complexity and strict regulatory documentation demands. (Mordor Intelligence, 2026)

#54

48% Pharma/Biotech (2024)

The pharma/biotech segment contributed nearly 48% of market revenue in 2024 per Toward Healthcare — with rising R&D spend, gene therapy pipelines, and biologics development all fuelling ELN dependency. (Toward Healthcare, 2026)

#55

8.25% CRO CAGR

Contract Research Organisations (CROs) are the fastest-growing ELN end-user segment with an 8.25% CAGR through 2031, reflecting the explosive outsourcing of pharmaceutical R&D functions globally. (Mordor Intelligence, 2026)

#56

12% Academic Share

Academic research institutions represent 12% of ELN market revenue — a segment that prizes open-source solutions and values reproducibility, suggesting strong growth potential as funding pressures ease. (Reanin, 2025)

#57

Food & Bev. Fastest (End-User)

Within end-user segments, food and beverage companies are expected to grow at the highest CAGR, as food safety traceability regulations and quality control digitalisation accelerate ELN adoption outside life sciences. (Toward Healthcare, 2026)

#58

8% Others Segment

The "others" segment — including forensics, industrial testing, and materials research — accounts for 8% of ELN revenue, representing an emerging frontier as ELNs expand beyond traditional life sciences labs. (Reanin, 2025)

#59

$1.6 Trillion US Pharma

The US pharmaceutical industry was valued at $1.6 trillion in 2023 — a massive ecosystem whose R&D and manufacturing digitisation requirements create an enormous long-term addressable market for ELN vendors. (Precedence Research, 2025)

#60

Life Sci. Largest (2024)

Life sciences held the largest end-user share in 2024 and registered the highest growth for the forecast period — making it the anchor segment for any ELN vendor's go-to-market strategy. (MarketsandMarkets, 2025)

#61

Large Orgs Dominant

Large organisations account for the dominant organisational size segment in ELN adoption, though SMEs are increasingly targeted through SaaS and freemium pricing models by vendors like Benchling and SciNote. (MarketsandMarkets, 2025)

#62

Service Segment Largest

The service component (implementation, training, support) held the largest ELN market share in 2024, driven by the complexity of validated deployments in pharma GxP environments requiring extensive change management. (MarketsandMarkets, 2025)

#63

529 FDA Warnings (2024)

The FDA issued 529 warning letters in 2024, with 8% targeting data integrity concerns — directly motivating laboratories to adopt validated ELNs with audit trails and electronic signature capabilities. (Codephusion, 2026)

#64

$2M+ OAI Remediation

Remediation of an FDA Official Action Indicated (OAI) can exceed $2M in consulting fees, re-inspections, and lost production — making ELN investment a compelling risk-reduction strategy for pharma operations. (Qualityze, 2026)

#65

90,000+ SciNote Users

SciNote ELN serves over 90,000 researchers in more than 100 countries, including labs at the FDA and USDA — demonstrating the global reach of even mid-market ELN providers in regulated environments. (SciNote, 2023)

#66

Drug Discovery Led

Drug discovery is the leading application for ELN software by spend, followed by clinical research, quality control, and data management — reflecting pharma's outsized investment in digital R&D infrastructure. (Spherical Insights, 2026)

#67

Molecular Bio, Genetics

In life sciences, ELNs are most heavily used in molecular biology, genetics, biochemistry, pharmacology, and microbiology — fields producing high-volume experimental data demanding structured digital capture. (Allied Market Research)

#68

53.4% Lab Informatics (2025)

Laboratory informatics solutions are expected to account for 53.4% of the ELN market share by solution in 2025 — a segment that integrates ELN, LIMS, and QMS into unified research data ecosystems. (Future Market Insights, 2025)

⚡

ROI, Productivity & Operational Benefits

Stats #69–84

"On average, researchers save 9 hours per week by using an ELN, while doing the same amount of work. For some researchers, time savings amount to 17 hours/week — equivalent to more than two full working days freed up for high-value research."
— SciNote ELN ROI Study, Scientific Computing World

#69

9 hrs/week Saved

Researchers save an average of 9 hours per week after ELN implementation — a remarkable productivity gain equivalent to adding 22.5% more productive research time per week without hiring new staff. (SciNote / Scientific Computing World)

#70

Up to 17 hrs/week

High-efficiency ELN users report time savings reaching 17 hours per week — more than two full working days reclaimed from administrative tasks and redirected toward active scientific discovery. (SciNote ELN ROI Study)

#71

33% Reporting Reduction

ELN users spend 33% less time on reporting tasks — largely due to auto-generated project reports and structured templates that eliminate manual copy-paste workflows common in paper-based labs. (SciNote ELN ROI Study)

#72

16% Scheduling Reduction

Researchers save 16% of time previously spent on scheduling and planning after ELN adoption, enabled by integrated workflow calendars, protocol templates, and shared experiment timelines. (SciNote ELN ROI Study)

#73

6% Email Reduction

ELN adoption reduces time spent on email by 6%, as centralised notebook sharing and in-platform notifications replace scattered email threads for experiment updates and data sharing. (SciNote ELN ROI Study)

#74

ROI in 3–4 Months

Electronic lab notebooks can deliver measurable return on investment within just 3–4 months of implementation — making the business case for ELN adoption unusually strong relative to other enterprise software categories. (SciNote, 2023)

#75

5 hrs/week Extra Research

SciNote users report up to 5 additional hours per week that can be reinvested directly into research or work-life balance — a compelling personal productivity case driving grassroots ELN adoption. (SciNote, 2023)

#76

6/7 Users Report Savings

6 out of 7 ELN users reported substantial time savings after transitioning from paper notebooks — an adoption satisfaction rate that rivals best-in-class enterprise software categories. (BioaccessLA, 2025)

#77

3 hrs/month Reporting

One PhD researcher at the University of Stavanger reduced weekly reporting from 3 hours to just 3 hours per month after ELN adoption — a 75% reduction validating ELN's transformative impact on documentation overhead. (Scientific Computing World)

#78

Audit Readiness

ELNs reduce audit preparation time significantly by providing instant access to timestamped, immutable records — directly addressing the regulatory requirement for ALCOA+ compliant data management in pharma and biotech. (DIMA Engineering, 2025)

#79

Inventory Cost Reduction

ELNs integrated with LIMS automate inventory control, ordering, and equipment calibration tracking — reducing material waste, avoiding reagent expiry losses, and lowering supply chain costs in research labs. (DIMA Engineering, 2025)

#80

Reduced Physical Storage

ELN adoption eliminates the need for physical paper storage — with a typical large pharma lab historically maintaining thousands of paper notebooks, the space and administrative savings alone can justify implementation costs. (DIMA Engineering, 2025)

#81

Real-Time Collab.

ELNs enable multiple researchers to work simultaneously on the same notebook — a collaborative capability impossible with paper, which accelerates multi-disciplinary project timelines and reduces knowledge silos. (LabKey, 2026)

#82

Data Loss Prevention

ELNs provide backup and restoration capabilities that safeguard against data loss — a critical advantage given that lost paper notebooks can represent months of irreplaceable experimental work and intellectual property. (BioaccessLA, 2025)

#83

Sustainability Impact

ELN adoption contributes to laboratory sustainability by reducing paper consumption, lowering physical storage energy requirements, and contributing to green laboratory initiatives aligned with ESG corporate mandates. (BioaccessLA, 2025)

#84

IP Protection

ELNs create tamper-proof electronic records with date/time stamps and digital signatures — critical for patent applications, IP litigation, and proof of invention date in competitive pharmaceutical R&D environments. (DIMA Engineering, 2025)

🏆

Competitive Landscape, M&A & Technology Trends

Stats #85–100

📅 Key Market Events Timeline (2023–2026)

2023

Avantor + Labguru integration announced — combining e-commerce inventory with ELN/LIMS. Market estimated at $480–613M across analyst frameworks.

May 2024

Sapio Sciences launches Sapio ELN; Certara acquires ChemAxon for cheminformatics depth; Revvity launches ChemDraw integration into Signals Research platform.

Jul–Aug 2024

Scilligence introduces ELN4edu for academic research. Skills Corporation opens Singapore R&D Centre for APAC ELN expansion.

Oct 2024

Thermo Fisher Scientific integrates AI/ML into its expanded ELN suite — enabling real-time data insights and intelligent decision support for bench scientists.

Sept 2024

LabArchives releases enhanced platform with real-time data sharing and expanded collaboration tools for academic and corporate research settings.

Jan 2025

LabArchives introduces mobile-first ELN app with offline data entry, image capture, and speech-to-text lab notes — targeting field researchers and remote lab professionals.

Apr 2025

Siemens closes $5.1B acquisition of Dotmatics, projecting $100M mid-term annual synergies and opening a $11B life-sciences total addressable market.

May 2025

MarketsandMarkets projects ELN market at $1.03B by 2030. Avantor and Labguru announce expanded 2025 partnership for LIMS-ELN combined platform.

#85

$5.1B Siemens-Dotmatics

Siemens' $5.1B acquisition of Dotmatics in April 2025 is the largest ELN-adjacent M&A deal in recent memory, expanding its Digital Twin portfolio into an $11B life-sciences TAM with $100M projected synergies. (Mordor Intelligence / Siemens AG, 2025)

#86

55% Top-5 Market Share

The top 5 ELN firms — Revvity, Dassault Systèmes, Benchling, Thermo Fisher, and Waters — collectively hold ~55% of the global market, leaving 45% fragmented among 115+ niche and regional vendors. (Industry Research Biz, 2026)

#87

Thermo Fisher AI Suite

In October 2024, Thermo Fisher expanded its ELN suite with AI/ML capabilities for real-time data analysis — a strategic move targeting pharma clients who need intelligent data insights embedded directly in experimental workflows. (SkyQuestTT, 2025)

#88

ChemAxon Acquisition

Certara's 2024 acquisition of ChemAxon strengthened its cheminformatics capabilities within model-informed drug development — reflecting consolidation toward integrated R&D data platforms that include ELN functionality. (Mordor Intelligence, 2026)

#89

ELN4edu Launch (2024)

Scilligence's ELN4edu, launched in July 2024, specifically targets academic institutions — providing tailored tools for educational collaboration, experiment management, and structured data sharing among student researchers. (Coherent Market Insights, 2025)

#90

FedRAMP LabArchives

LabArchives achieved FedRAMP authorization and GovRAMP membership — enabling US federal government agencies to adopt its ELN platform with confidence that security standards meet NIST 800-53 requirements. (LabArchives, 2025)

#91

ISO 27001 (SciNote)

SciNote holds ISO 27001 certification and serves researchers at the FDA and USDA — demonstrating that even mid-market ELN providers are achieving enterprise-grade information security credentials. (SciNote, 2023)

#92

Körber + LabWare (2023)

Körber AG and LabWare announced the "PAS-X LIMS Integration" program in November 2023, integrating manufacturing execution systems with LIMS — a trend toward end-to-end digital lab ecosystems spanning production and R&D. (MarketsandMarkets, 2025)

#93

12.8% Cloud ELN CAGR

The global laboratory cloud ELN market is growing at a 12.8% CAGR through 2033, significantly faster than the overall ELN market — confirming that cloud-first deployment is the defining strategic shift of this decade. (Growth Market Reports, 2025)

#94

$2.4B Cloud ELN by 2033

The global laboratory cloud ELN market is forecasted to reach $2.45B by 2033 from $823.7M in 2024 — a near-tripling that underscores cloud's role as the primary engine of ELN market expansion. (Growth Market Reports, 2025)

#95

eLabFTW 12+ Year OSS

Open-source ELN eLabFTW has maintained active development for over 12 years with 41+ contributors — providing regulated labs a transparent, auditable alternative to proprietary systems at near-zero licensing cost. (PLOS Computational Biology, 2024)

#96

9.5% CAGR (ELN Soft. 2033)

The ELN software market specifically is projected to grow at 9.5% CAGR from 2025 to 2033 — among the fastest in the broader laboratory informatics sector — driven by AI-powered automation and cloud-native architecture. (Data Insights Market, 2025)

#97

Vendor Lock-In Risk

Proprietary ELN formats create vendor lock-in risk — a significant concern for research organisations whose data longevity spans decades, driving demand for interoperable, open-standard ELN solutions. (PLOS Computational Biology, 2024)

#98

LIMS-ELN Convergence

The integration of ELN into LIMS is a key market trend — future-proofing laboratory data management by creating unified ecosystems where sample tracking, experiment documentation, and QC data reside in one searchable platform. (Toward Healthcare, 2026)

#99

Mobile-First ELN (2025)

LabArchives' January 2025 launch of a mobile-first ELN app with offline capability, speech-to-text, and image capture signals a new era of bench-side, field-accessible digital lab documentation beyond desktop workstations. (Coherent Market Insights, 2025)

#100

$11B Life Sci TAM

Siemens projects an $11 billion total addressable market in life sciences following the Dotmatics acquisition — signalling that ELN software sits at the intersection of pharma's most strategic digital investment priorities for the decade ahead. (Mordor Intelligence / Siemens AG, 2025–2026)

The Digital Lab Revolution:100 Key Statistics Defining theELN Software Industry in 2026

The Digital Lab Revolution:
100 Key Statistics Defining the
ELN Software Industry in 2026